These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane. Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518 [TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532 [TBL] [Abstract][Full Text] [Related]
10. Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica. Chihara N; Aranami T; Oki S; Matsuoka T; Nakamura M; Kishida H; Yokoyama K; Kuroiwa Y; Hattori N; Okamoto T; Murata M; Toda T; Miyake S; Yamamura T PLoS One; 2013; 8(12):e83036. PubMed ID: 24340077 [TBL] [Abstract][Full Text] [Related]
11. Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica. de Andrés C; Teijeiro R; Saiz A; Fernández P; Sánchez-Ramón S Neurologia; 2015 Jun; 30(5):276-82. PubMed ID: 24674779 [TBL] [Abstract][Full Text] [Related]
12. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545 [TBL] [Abstract][Full Text] [Related]
13. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579 [TBL] [Abstract][Full Text] [Related]
14. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. Jarius S; Franciotta D; Paul F; Ruprecht K; Bergamaschi R; Rommer PS; Reuss R; Probst C; Kristoferitsch W; Wandinger KP; Wildemann B J Neuroinflammation; 2010 Sep; 7():52. PubMed ID: 20825655 [TBL] [Abstract][Full Text] [Related]
16. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309 [TBL] [Abstract][Full Text] [Related]
17. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Kalluri SR; Illes Z; Srivastava R; Cree B; Menge T; Bennett JL; Berthele A; Hemmer B Arch Neurol; 2010 Oct; 67(10):1201-8. PubMed ID: 20937947 [TBL] [Abstract][Full Text] [Related]